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HCVNS3proteinplaysacentralroleinviralpolyproteinprocessingandRNAreplication.Wedemonstrate
thattheNS3protease(NS3
pro)domainalonecanspecificallybindtoHCV-IRESRNA,predominantlyinthe
SLIV region. The cleavage activity of the NS3 protease domain is reduced upon HCV-RNA binding. More
importantly, NS3
pro binding to the SLIV hinders the interaction of La protein, a cellular IRES-trans acting
factorrequiredforHCVIRES-mediatedtranslation,resultingininhibitionofHCV-IRESactivity.Although
overexpression of both NS3
pro as well as the full length NS3 protein decreased the level of HCV IRES
mediated translation, replication of HCV replicon RNA was enhanced significantly. These observations
suggest that the NS3
pro binding to HCV IRES reduces translation in favor of RNA replication. The
competition between the host factor (La) and the viral protein (NS3) for binding to HCV IRES might
regulate the molecular switch from translation to replication of HCV.
V
arious stages of viral life cycles are coordinated by a complex interplay of viral proteins and host (cellular)
factors. In positive strand RNA viruses, the switch from translation, the initial obligatory step post-
infection, to replication, the essential step for viral proliferation, is thought to be mediated by multiple
interactions between viral and cellular proteins. Hepatitis C virus (HCV) non-structural protein 3 (NS3) plays a
centralroleinpolyproteinprocessingandviralRNAreplication.ThemultifunctionalenzymeHCV-NS3hastwo
major domains: the serine protease domain (1–180aa) and helicase domain (181–632aa)
1. NS4A act as the
cofactor for its protease activity. The DExH/D-box helicase activity of NS3 is an important component of the
replicative complex of the virus. On the other hand, the protease activity has been reported to enhance the RNA
binding
2 and duplex unwinding
3 abilities of NS3 helicase, indicating a direct or indirect role of NS3 protease in
RNAreplication.Interestingly,theproteasedomainbeingthemostpositivelychargedregionoftheNS3protein
2
raises the question whether it can bind to HCV RNA by itself.
HCV proteins are synthesized by the IRES mediated translation of the viral genomic RNA, which is the initial
obligatory step after infection. Once viral proteins are synthesized, the viral RNA is replicated. However the
mechanism of switch from translation to viral RNA replication is not well understood. Earlier, PCBP2 (an IRES
transactingfactor,ITAF)and3CD(viralprotein)havebeenshowntoplayroleintheswitchforpoliovirusRNA
4.
ThestudyprovidedevidenceofacomplexinterplaybetweentheviralandcellularproteininbindingtoviralRNA
and influencing the switch from translation to replication. Some canonical initiation factors (eIF2 and eIF3) and
non-canonical ITAFs, have been shown to interact with the HCV-IRES and influence its function
5, 6, 7, 8. Earlier,
results fromour laboratory andothers haveshown, thathuman La autoantigen binds toHCVIRES RNAbothin
vitro and ex vivo and help in ribosome assembly during internal initiation of translation of HCV RNA
5, 9, 10. The
central RNA recognition motif (RRM 112–184) of human La protein was shown to interact at the GCAC near
initiator AUG and trigger a conformational alteration, which facilitates 40S binding during internal initiation
11.
La protein has also been shown to bind 39UTR and might help in HCV RNA replication
12.
As the NS3
pro is thought to be involved in HCV replication and La is involved in translation, we investigated
whether the translation-replication switch in HCV is regulated by interplay between NS3
pro and La, and if the
regulation is mediated by the ability of these proteins to bind the HCV RNA.
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NS3 protease specifically interacts with HCV IRES RNA. To
investigate whether the protease domain of the NS3 protein
(Fig. 1a) is capable of binding to HCV IRES RNA, direct RNA-
protein UV cross linking assay was performed using purified NS3
protease from plasmid pYB43
13. Additionally, the above experiment
was repeated to analyze the binding at physiological salt
concentration i.e. 140mM KCl (Supplementary Information,
Fig. S1a). The results showed that NS3
pro interacts efficiently with
HCV IRES and the binding increases with increasing protein
concentration (Fig. 1b). Interestingly, NS3
pro showed no
appreciable binding with the HCV 39UTR (Supplementary
information, Fig S1b). Further, to demonstrate that NS3 protein
indeed binds to HCV IRES RNA, the ribonucleoprotein (RNP)
Figure 1 | NS3
prospecificallybindstoHCVIRESRNA. Panela:SchematicrepresentationofthedomainorganizationofHCVNS3protein.Panelb:UV-
crosslinking.[a
32P]UTPlabeledHCVIRESRNAwasUVcrosslinkedwithincreasingconcentrations(0.1,0.2,0.4and0.8mM)ofNS3
pro(lane2–5).Lane
1 shows only probe control. Schematic representation of the NS3
pro protein is shown above the panel. Panel c: Immuno-pulldown assay and RT-PCR.
NS3-RNA complex was immunoprecipitated from HCV replicon bearing cells using anti-NS3 antibody. RNA was isolated and RT-PCR was performed
forHCVIRES(lane3).Noantibody(lane1)andanti-actinantibodies(lane2)wereusedasnegativecontrolsforthepulldown.Paneld:CompetitionUV-
crosslinking. [a
32P]UTP labeledHCVIRES RNAwasUVcrosslinked withNS3
prointheabsence (lane2)andpresence ofmolarexcess ofunlabeledHCV
IRESRNA(lanes3–5)oranonspecific RNA(lanes6–8).Lane1showsonlyprobecontrol. Panele:SchematicrepresentationofHCVIRESRNAshowing
the stem and loop (SL) regions
20. The domains that are used as SLII, III and IV in the study are encircled and indicated. Panel f: UV-crosslinking.
[a
32P]UTPlabeledHCVSLII(lane2–3);SLIII(lane5–6)andSLIV(lane8–9)RNAswereUVcrosslinkedtoincreasingconcentrations(0.2and0.4mM)of
NS3
pro. Lanes 1, 4 and 7 represents only probe controls for SLII, SLIII and SLIV respectively. Panel g: RNase T1 Foot-printing assay. Binding reactions of
invitrotranscribedHCVIRESRNAwerecarriedoutinabsence(lane6)orpresence(lane7)ofNS3protease.TheRNAwasthendigestedwithRNaseT1.
RNA was reverse-transcribed with an end labeled primer. The cDNA was resolved in along with a reference sequencing reaction (lanes 1–4). Lane 5
represents the no T1 control. Panel h: Filter-binding assay. [a
32P]UTP labeled HCV IRES RNA or mutant IRES RNA (M1 and M2) was bound to
increasing concentrations of NS3
pro.
www.nature.com/scientificreports
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replicon (generous gift from R. Bartenschlager), was immuno-
precipitated using anti-NS3 antibody. Anti-actin antibody was
used as negative control. The HCV IRES RNA was detected by
RT-PCR using the RNA isolated from the pull-down complex
(Fig. 1c, lane 3). Additionally, we have observed considerable
binding of full length NS3 protein with the HCV IRES RNA
(Supplementary information, Fig. S1c). Results reconfirm the
interaction of NS3 protein with HCV IRES RNA.
The interaction between
32P IRES RNA and NS3
pro was further
examined by competition UV cross linking experiment with 100,
200and400foldmolarexcessofunlabeledselfRNAoranon-specific
RNA(Nsp),whichshowedthespecificityoftheinteraction(Fig.1d).
NS3
pro did not bind Polio IRES efficiently (Supplementary
Information, Fig. S2a). Further, NS3
pro showed greater affinity for
the IRES RNA derived from positive strand compared to the corres-
ponding negative strand RNA (data not shown).
Also, it was observed that the protease domain binds to both SLIII
(nt121- 290) and SL IV (nt291- 383) regions more efficiently com-
pared to SLII (nt18- 123) RNA (Fig. 1e and f). Competition UV
cross-linking assay using cold competitor RNA (200 and 400 fold
molar excess) corresponding to different stem-loop region recon-
firmed the observation and showed significant competition with
SLIV RNA (Supplementary Information, Fig. S2b). Results suggest
that NS3
pro might bind to HCV IRES at different pockets but pre-
dominantly at the SLIV region which harbors the iAUG and also
contains La binding sites critical for translation initiation.
To characterize the binding sites of the NS3
pro within IRES RNA,
toe-printing assay was carried out. Prominent toe-prints corres-
ponding to NS3
pro were observed at G328, G331, G335, G337,
G344, and G346 (Supplementary Information, Fig. S3a). Similarly,
RNaseT1 foot-printing assay showed prominent foot prints at G323,
G331 and G344 in stem loop IV region (Fig. 1g). Also, minor foot
printswereobservedatG335andG337suggestingthatNS3
promakes
primary contact between G328-G344 within HCV IRES (Fig. 1g,
Supplementary Information, Fig. S3b).
Since human La protein was also shown to bind at similar region,
two mutant HCV IRES RNAs (M1 and M2) (Supplementary
Information, Fig. S4a) were used that are known to have reduced
affinity for binding to La protein
11. Results showed drastic decrease
in RNA binding of NS3
pro with these mutants, suggesting a signifi-
cantoverlapbetweenbindingsitesofLaandNS3
prointheHCVIRES
(Fig 1h), Supplementary Information, Fig. S4b).
Effect of RNA binding on NS3
pro cleavage activity. To investigate
whether the RNA binding of NS3
Pro had an effect on the canonical
proteolytic activity of NS3
pro, NS3 cleavage assay was performed in
the absence or presence of HCV IRES RNA. For cleavage, NS5A/5B
substratewasusedthatharborstheNS3cleavagesiteattheNS5A/5B
junction. In presence of NS3
pro, distinct cleavage product was
obtained which showed dose dependent decrease upon addition of
HCVIRESRNAbutnotwithnonspecificRNA(NspRNA)(Fig.2a).
Interestingly,additionofexcessenzyme(NS3
pro),butnotBSA,could
rescue the inhibition, possibly by titrating out the RNA and
rendering NS3
pro available to cleave the substrate (Fig. 2b). This
was reconfirmed by addition of antisense IRES RNA which could
successfully rescue the inhibitions of cleavage activity (Fig. 2c).
Furthermore, presence of mutant HCV IRES (M1 and M2) RNA
harboring mutations in NS3
pro binding region did not show
significant reduction of cleavage activity (Fig. 2d). The results
suggest binding with HCV IRES RNA reduces the proteolytic
activity of NS3
pro.
The catalytic triad of NS3 protease is composed of three amino
acid residues: His-57, Asp-81, and Ser-139. Since Ser139 has been
shown to be critical for the catalytic activity of NS3 protease and lies
in the C terminal half of NS3 protease domain (which has been
shown to bind HCV IRES), we generated a mutant NS3
pro which
harbors substitution mutations (serine to alanine) at ser138 and
ser139 (Supplementary Information, Fig. S5a). The purified recom-
binant mutant NS3
pro (Supplementary Information, Fig. S5b) failed
to show the cleavage activity (Fig 2e) and also showed a drastic
reduction in HCV IRES RNA binding in the filter binding assay
(Fig 2f) and UV cross linking assay (Supplementary Information,
Fig. S5c).
Effect of NS3
pro binding on HCV IRES function. Since the NS3
pro
bindstoSLIVregionnearinitiatorAUG,whichplaysacrucialrolein
HCV IRES-mediated translation, we investigated the possible effect
on the IRES function. in vitro translations using capped HCV
bicistronic RNA (cap-Rluc-HCV IRES-Fluc) in presence of NS3
pro
showed significant inhibition of HCV IRES mediated translation of
Fluc(Fig.2g).However,themutantNS3
profailedtoinhibitHCVIRES
function(Fig2g).Additionally, whenthefulllengthNS3proteinwas
used in the assay, a similar degree of inhibition was observed
suggesting that NS3 protease domain binds to HCV IRES and
inhibits translation in the context of full length NS3 protein
(Fig. 2h). Interestingly, addition of increasing concentration of La
protein could successfully rescue the NS3
pro mediated inhibition of
HCV IRES function whereas a mutant La protein (P4-La), which
lacks the binding ability near SLIV
14 failed to rescue the inhibition
(Fig 3a). Additionally, transient co-transfection of NS3
pro encoding
plasmid along with the HCV bicistronic construct in Huh7 cells
showed dose dependent inhibition of HCV IRES mediated
translation (Supplementary Information, Fig. S6a). Also, when
tested in similar reaction conditions, Poliovirus IRES mediated
translation did not show reduction due to HCV NS3 protease
(Supplementary Information, Fig. S6b). A possible mechanism of
this inhibition is that NS3
pro binding to SLIV region competes with
the binding of important transacting factors and consequently
inhibits the IRES function.
The interplay between NS3
pro and La protein for binding to SLIV
within HCV IRES. Since La is known to bind to HCV IRES near the
initiatorAUG,withanoverlappingbindingsitewithNS3
pro,wehave
explored whether the binding of the two proteins was antagonistic.
Competition UV crosslinking assay using increasing concentrations
of NS3
pro, showed increased binding of NS3
pro with HCV SLIV and
corresponded with reduction in La binding (Fig. 3b). Conversely,
addition of increasing concentrations of La protein resulted in
gradual decrease in NS3
pro binding (Fig. 3c) confirming the
antagonistic binding between these two proteins. Mutant La
protein (P4-La) did not show appreciable competition with NS3
pro
forbindingtoHCVSIV(Fig3d)confirmingthatbothNS3
proandthe
wild type La protein bind to a similar region in SLIV. More
importantly, La protein could successfully compete with the full
length NS3 protein for binding to the HCV IRES (Fig 3e). These
observations suggest that the mutually antagonistic binding of NS3
and La protein with the SLIV of HCV IRES may constitute a
molecular switch from translation to replication of viral RNA.
HCV translation versus replication: role of NS3
pro. To investigate
the possible role of NS3
pro in replication of HCV RNA, pSGR JFH1
luc replicon RNA
15 was transiently cotransfected with either
NS3
pro encoding construct or vector DNA. At different time points
(0, 6, 12, 18 and 24 hour) HCV negative strand RNA was quantified
by semi quantitative RT PCR (Fig. 4a–d). GAPDH was used
as an internal control. Over expression of NS3
pro (Fig. 4b), but
not of mutant NS3
pro (Fig. 4c) or vector control (Fig. 4a,
Supplementary information, Fig S7) showed increased level of
HCV negative strand at 18
th hour. Over expression of Core protein
did not show appreciable changes in the levels of negative strand
RNA (Fig 4d).
www.nature.com/scientificreports
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ferenttimepoints,starting6hrposttransfection,luciferaseassaywas
performed (Fig. 4e). Ratios of HCV RNA amplified (representing
replication) and luciferase synthesis (representing translation) at
each time point showed that HCV negative strand RNA level at
18hrposttransfectionwasaround3.5foldhigherthanvectorcontrol
(Fig 4f). However, under same conditions, luciferase translation
from the same replicon showed no concomitant increase, suggesting
an adverse effect on IRES function. Interestingly, overexpression
of HCV-core protein (known to inhibit HCV IRES function)
also showed no significant change in the level of replication to trans-
lation ratio.
Although, NS3
pro binding to HCV IRES was found to dislodge the
La protein binding with SLIV region and inhibit translation, over-
expression of La protein in Huh7 cells didn’t show appreciable
change in replication profile of the negative strand (Supplementary
Figure 2 | Effectof HCVRNA bindingon thecatalytic activity of NS3protease. Panela:Recombinant NS3proteasewasallowed toformcomplexwith
increasing amount of unlabeled HCV IRES RNA (lanes 3–4). Lane 2 shows the control without HCV IRES RNA. NS5A/5B protein was used as the
substrateforNS3
pro.Lane1showssubstratealone.NonspecificRNAhasbeenused(lane5)totestforthespecificityofthereaction.Panelb:Cleavageassay
wascarriedoutinthepresenceofHCVIRESRNA.Thecleavageinhibition(lane3)causedbytheRNAwasrescuedbyadditionofexcessamountofNS3
pro
(lanes 4–5). BSA was used as a negative control (lanes 6–7). Panel c: Cleavage assay was carried out in the presence of HCV IRES RNA. The cleavage
inhibition (lane 3–4) caused by the RNA was rescued by addition of increasing concentrations of antisense RNA (lanes 5–6). Panel d: Cleavage assay in
presenceofthetwomutantHCVIRESRNAs(M1andM2).Panele:CleavageassayusingincreasingconcentrationsofwildtypeNS3
pro(lanes2and3)and
mutant NS3
pro (lanes 4 and 5). Panel f: Filter-binding assay. [a
32P]UTP labeled HCV IRES RNA was bound to increasing concentrations of NS3
pro and
mutant NS3
pro. Panel g: In vitro transcribed capped bicistronic RNA (shown above panel) was in vitro translated in the absence or presence of increasing
concentrations (0.2 and 0.4mM) of either NS3
pro or mutant NS3
pro. Luciferase assay was performed. Percent luciferase activities corresponding to
Rluc (white bar) and Fluc (grey bar) values were plotted against the protein concentrations. Values which significantly differ from control
(P value,0.001) are indicated as asterisks. Panel h: In vitro transcribed capped bicistronic RNA was in vitro translated in the absence or presence of
increasing concentrations of either NS3
pro (0.2 and 0.4mM) or full length NS3 (0.2 and 0.4mM). Luciferase assay was performed. Percent luciferase
activities corresponding to Rluc (white bar) and Fluc (grey bar) values were plotted against the protein concentrations.
www.nature.com/scientificreports
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tration of pCDLa showed overexpression of La protein but
didn’t show corresponding change in the negative strand RNA syn-
thesis. However, in a similar experiment overexpression of NS3
pro
showed considerable increase in the negative strand synthesis
(Supplementary information, Fig S9).
Finally, to reconfirm our observation the replication complex was
immunoprecipitated by using antiNS5B antibody and the RNA iso-
latedfromthecomplexwasmeasuredfornegativestrandbyRT-PCR
analysis. Results clearly showed considerable increase of negative
strand synthesis in the immunoprecipitate from the cells transfected
with NS3
pro overexpressing plasmid construct (Fig 4h).
We have also assayed the negative strand synthesis more quanti-
tatively using real time RT-PCR. Results showed approximately 3.5
fold increase in negative strand synthesis (between 6–18hrs post
transfection) upon overexpression of NS3
pro (Supplementary
information, Fig. S9).
Additionally,toruleoutDNAcontaminationinRNAsamplesand
verify the specificity of the negative strand primers used in the RT-
PCR analysis several control experiments were performed
(Supplementary information, Fig S10).
NS3-FL also supports the switch from translation to replication.
To further investigate the switch from translation to replication
puromycin and cycloheximide were used that induce the
dissociation and freezing of polysomes respectively and have the
opposite effects on negative strand RNA synthesis. For this
purpose, Huh7 cells were transfected with HCV replicon and
treated with the respective drugs followed by detection of negative
strand synthesis at different time points.
Figure 3 | Panel a: In vitro transcribed capped bicistronic RNA was in vitro translated in the absence or presence of NS3
pro. Luciferase assay was
performed.PercentluciferaseactivitiescorrespondingtoRluc(whitebar)andFluc(greybar)valueswereplottedagainsttheproteinconcentrations.The
translationinhibitionwasrescuedbyaddingequimolarandalso2foldmolarexcessofwildtypeLaprotein.P4-Lamutantwasusedasanegativecontrol.
Valueswhichsignificantlydifferfromcontrolareindicatedasasterisk.**indicatesPvalue,0.001and*indicatesPvalue,0.01.Panelb:UV-crosslinking
assay: [a
32P] UTP labeled HCV SLIV RNA was UV crosslinked with La protein (0.2 mM) in the presence of equimolar, 2 fold, 4 fold, 8 fold and 10 fold
molarexcessofpurifiedHCVNS3
pro(lanes3–7).ThepositionofNS3
proandLaproteinisindicated.Lane1and2representsbindingduetoNS3
proandLa
protein alone respectively. Panel c: UV-crosslinking assay: [a
32P]UTP labeled HCV SLIV RNA was UV cross linked to NS3
pro (0.2 mM) in the presence of
equimolar, 2 fold, 4 fold, 8 fold and 10 fold molar excess La protein (lanes 2–6). Lane 1 and 7 represents binding due to NS3
pro and La protein alone
respectively.Paneld:UV-crosslinkingassay:[a
32P]UTPlabeledHCVSLIVRNAwasUVcrosslinkedtoNS3
pro(0.2mM)inthepresenceofequimolaror2
foldmolarexcess ofeither wild typeLaprotein(lanes4and5)orP4-La(lanes6and7).Lanes1,2and3represent bindingduetoNS3
proandwild typeLa
protein and P4-La alone respectively. Panel e: UV-crosslinking assay: [a
32P] UTP labeled HCV SLIV RNA was UV crosslinked with the purified
recombinant full-length NS3 protein (0.3mM) in the presence of equimolar, 2 fold, and 4 fold molar excess of the La protein (lanes 3–5). The position of
NS3 and La protein is indicated. Lane 1 and 2 represents binding due to NS3-FL (0.3mM) and La protein (0.3mM) alone respectively.
www.nature.com/scientificreports
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strands is expected to interfere with hybridization-based methods of
quantification of minus strand (semiquantitative RT-PCR), to spe-
cifically detect the negative strands ‘two-cycle RNase protection’
assays were performed in parallel
16. Results clearly showed that
treatment with puromycin resulted in considerable increase in nega-
tivestrandsynthesisat18
thhourposttransfection(Fig5a).However,
treatment with cycloheximide showed gradual decrease in negative
strandsynthesis(Fig5b).Theseresultsareconsistentwiththemech-
anism of action of the two compounds.
Similarly, the effect of over expression of NS3 protease on HCV
negative strand synthesis was further investigated using ‘two cycle
RNase protection assay’. The results showed significant increase of
negative strand synthesis at 18 hour time point upon over expres-
sions of NS3 protease (Fig 5d). More importantly, similar obser-
vation was made with the over expressions of full length NS3
(Fig 5e). However, mutant NS3 protease failed to enhance the nega-
tive strand synthesis to the same extent (Fig 5f).
To further validate above observations, we repeated the experi-
ment using the rTth RT-PCR method which rules out the self prim-
ing and miss priming events
17 (Fig. 5g). Again, the results showed
increaseinnegativestrandRNAsynthesistoasimilarextentafterthe
overexpression of NS3
pro.
Additionally, to discriminate between negative strands versus a
vast excess of positive-strands, RT-PCR with a tagged cDNA syn-
thesis primer was used to selectively measure the level of negative
strand synthesis
18. Results (Fig. 5h) reconfirmed the earlier observa-
tions. Interestingly, over expression of the full length NS3 protein
also showed considerable increase in the negative strand synthesis as
observed after NS3
pro over expressions (Fig. 5i). Results suggest that
the full length NS3 protein also supports the switch.
Finally, over expression of NS3
pro in the context of all the viral
proteins,wasinvestigated with theHCV-H77S RNA(agenerousgift
from Stanley Lemon, University of Texas, Galveston)
19 in HCV cell
culture assay which showed that NS3
pro overexpression advances the
replication of H77S RNA (Fig 6a) whereas overexpression of core
protein did not show similar effect (Fig. 6b and 6c).
Discussion
The two domains of NS3 protein (protease and helicase) are func-
tionally coupled. It has been shown that helicase domain binds to
HCVRNAmoreeffectivelyiftheproteasedomainisincluded.Inthis
Figure 4 | EffectofNS3
prooverexpressiononHCVRNAreplicationversustranslation. Huh7cellswerecotransfectedwithofpSGRJFH1/LucRNAand
construct expressing NS3
pro, or vector or mutant NS3
pro or core. RNA was isolated at different time points and HCV RNA was quantitated using semi
quantitative RT PCR (left side of Panel a, b, c and d). GAPDH was used as internal control (right hand side of Panel a, b, c and d ). Panel e: For the
experiments performed in fig. 4a–d, luciferase assay was carried out to detect translation levels. The percentage luciferase activities were plotted for each
reaction at different time intervals taking 6 hour time point as 100 (control). Panel f: The ratio of percentage of replication to translation levels in vector
control cells was compared with cells overexpressing NS3
pro plasmid or the other controls and graphically represented by plotting ratio of percentage
replicationversustranslationonYaxisandtimeonXaxis.Panelg:RNAproteincomplexwaspulleddownat18
thhourtimepointfromcellscotransfected
with pSGR JFH1/Luc RNA and construct expressing NS3
pro using anti-NS5B antibody followed by RT-PCR for HCV IRES.
www.nature.com/scientificreports
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pro independently binds HCV geno-
mic RNA which in turn affects its protease activity. The binding of
NS3
pro to HCV IRES RNA has been found primarily due to the C
terminal half of the NS3 protease domain. The recombinant NS3
pro
used in the study also bears the NS4A core peptide (since NS4A is
required for catalytic activity of the protease). However, the C ter-
minal half of NS3
pro that is devoid of NS4A showed significant bind-
ing with HCV IRES (Supplementary Information, Fig. S11),
comparable to NS3
pro full-length, ruling out the possibility of any
contribution of NS4A core peptide to RNA binding.
Under normal conditions, transfection of HCV replicon RNA
showed accumulation of HCV RNA only after 24hr. Results from
this study clearly demonstrated that over expression of NS3
pro leads
to increased replication at 18hr post transfection while no concom-
itant increase in luciferase translation was observed from the trans-
fected HCV replicon RNA. Considering the half life of luciferase
between 6–8 hours and presence of abundant template RNAs, this
reflectssignificantdecreaseinHCV-IRESfunctionatthistimepoint.
Figure 5 | Panel a: Huh 7 cells were transfected with pSGR JFH1 luc RNA.
12hours after transfection, cells were treated with puromycin. At different
time points total cellular RNA was isolated and was subjected to two cycle
RNase protection assay. Negative strand RNA was probed using radiolabelled
positive strand HCV IRES RNA followed by RNAse digestion. Protected
fragment was detected by running on 4% polyacrylamide-8M urea gel. The
a r r o w( b e l o w1 2 h r )i n d i c a t e st h etime of addition of puromycin. Panel b:
Huh 7 cells were transfected with pSGR JFH1 luc RNA. 12hours after
transfection, cells were treated with cycloheximide. At different time points
total cellular RNA was isolated and was subjected to two cycle RNase
protection assay. Negative strand RNA was probed using radiolabelled
positive strand HCV IRES RNA followed by RNAse digestion. Protected
fragment was detected by running on 4% polyacrylamide-8M urea gel.
The arrow (below 12hr) indicates the time of addition of cycloheximide.
Panel c–f: Two cycle RNase protection assay was performed under similar
e x p e r i m e n t a ls e tu pa si nf i g . 4f o rv e c t o rc o n t r o l ,N S 3
pro, NS3 full length and
mutant. The total RNA was self hybridized followed by RNase treatment.
Negative strand RNA was probed using radiolabelled positive strand HCV
IRES RNA followed by RNAse digestion. Protected fragment was detected by
running on 4% polyacrylamide-8M urea gel. Panel g: Under similar
experimental set up as in fig. 4b, instead of semiquantitative RT-PCR,
negative strand was detected using thermostable RT-PCR. Panel h–i: Under
similar experimental set up as in fig. 4b, negative strand was detected using a
tagged cDNA. Here, cDNA was made using a HCV primer that was tagged
with alongnon HCV nucleotidetag. This was followed by first round of PCR
using tag only primer and HCV reverse primer. A second cycle nested PCR
was performed using 50 times diluted first PCR product by a second set of
internal primers. Similarly, the above assay was performed under over
expression of NS3
pro as well as NS3 full length protein as indicated (panel i).
Figure 6 | Panel a: Huh7 cells were cotransfected with H77S RNA
(schematic representation shown above panel) and the construct
encodingNS3
pro. RNAwasisolatedatdifferenttimepointsandHCVRNA
was quantitated using semi quantitative RT PCR. GAPDH was used as
internal control. Panel b: Huh7 cells were cotransfected with H77S RNA
and construct encoding HCV core. RNA was isolated at different time
points and HCV RNA was quantitated using semi quantitative RT PCR.
GAPDH was used as internal control. Panel c: Graph plotted taking
percentage replication of HCV RNA normalized with that of GAPDH
amplifiedonYaxisandtimeonXaxis.Whitebarindicatesoverexpression
of HCV core and grey bar indicates that of NS3
pro
www.nature.com/scientificreports
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pro in HCV replicon and
HCV cell culture systems could stimulate HCV RNA replication
indirectly by promoting HCV polyprotein cleavage and increasing
the abundance of NS5B and other ‘‘replication’’ proteins. However,
western blot analysis using anti-NS5B antibody did not show con-
siderable increase in NS5B protein expressions upon over expres-
sions of NS3
pro (Supplementary Information, Fig. S12). In fact
considerable decrease in NS5B was noticed which could be due to
inhibition of translation upon NS3
pro overexpression.
IRES mediated translation of the input RNA is the first step in
HCV life cycle inside the host cell after entry and release of genomic
RNA. To restrict the cytotoxicity of accumulated viral proteins, it is
essential to halt IRES function once the optimum level of viral pro-
teinsynthesisisachievedandswitchtoviralRNAreplication.Infact,
Zhang et al reported that HCV core protein binds to HCV IRES
(between nt 441–473) to inhibit translation and the authors specu-
lated that the down regulation in translation could be required to
favorinitiationoftranscription.However,themolecularmechanism
was not clear
20.
Interestingly,whenHuh7S10extractwasUVcrosslinkedtoHCV
SLIV RNA, several cellular proteins were found to interact including
p50, p54, p56 etc. Additions of purified NS3
pro protein apparently
competed out the binding of two proteins of approximate molecular
mass, p50 and p56. One of the proteins (p50) was immuno-
precipitated (Supplememtary Information, Fig. S13 a and b) with
anti-La antibody suggesting that NS3
pro competes out La protein
binding to HCV IRES in the context of Huh7 S10 containing other
cellular proteins.
Human La protein has been shown to be required for HCV IRES
mediatedtranslationaswellasreplication.Itistemptingtospeculate
that at the initial stage, La protein is engaged in translation of viral
RNA,while NS3
properforms viral polyprotein processing activity.At
thisstage,theconcentration ofNS3maynotbesufficient tocompete
out La protein binding to the IRES. As NS3 concentration rises, La
binding to the IRES is antagonized, and La and NS3 finally reach an
equilibrium state where the viral life cycle switches to replication
(Supplementary Information, Fig. S14).
Taken together, these observations provide insights into a novel
regulatory process involving the interplay between a viral and a host
protein which determines the essential switch from translation to
replication in the viral life cycle.
Methods
Over expression and purification of recombinant proteins. NS3 protease and
EGFP-NS5A/5B-CBD proteins were over expressed in E. coli using the pYB-43 and
pYB-44 plasmids (obtained as a kind gift from Itai Benhar) and purified as described
earlier
13.NS3
proisa fusion protein ofNS4A-NS3
pro,whichlacksthe helicase domain.
Similarly all other recombinant full-length or mutant proteins were overexpressed in
E coli and purified as described before
14. For replication studies pSGR JFH1 luc
construct was used
15.
in vitro transcription and translation. mRNAs were transcribed from different
plasmid constructs by run-off transcription reactions using T7 RNA polymerase
(Promega). Similarly radiolabeled mRNAs were transcribed in vitro using T7 RNA
polymerase and [a
32P]UTP.
In vitro translation of capped bicistronic RNA containing HCV IRES
(18–383nt) was carried out in a 15ml reaction containing 9ml nuclease treated
rabbit reticulocyte lysate (Promega), amino acid mix and RNase inhibitor (as per
manufacturer’s protocol). Renilla and firefly luciferase activity was measured
according to Promega protocol using dual luciferase assay system as described
earlier
14
UV-crosslinking assay. The [a
32P]UTP labeled RNA of interest was incubated with
the protein of interest at 30uC for 15 minutes in RNA binding buffer (containing
5mM HEPES pH 7.6, 25mM KCl, 2mM MgCl2, 3.8% Glycerol, 2mM DTT and
0.1mM EDTA). The reaction mixtures were then UV-cross-linked using a UV lamp
for 15 minutes. The reaction mixtures were then treated with RNase A followed by
SDS-PAGE analysis and phosphor imaging. For non specific RNA control pGEMT-
Easy vector was religated and digested with Sac1 in the polylinker. This template was
in vitro transcribed to obtain RNA against the polylinker region which was used as a
nonspecific RNA control.
Filter binding assay. The [a
32P]UTP labeled RNA was incubated with the protein of
interest at 30uC for 15 minutes in RNA binding buffer (containing 5mM HEPES
pH 7.6, 25mM KCl, 2mM MgCl2, 3.8% Glycerol, 2mM DTT and 0.1mM EDTA)
followed by filter binding assay as described earlier
14.
RibonucleaseT1footprinting.RNAbindingreactionswerecarriedoutusinginvitro
transcribed HCV IRES (18–383nt) RNA (4mg) in absence or presence of NS3
pro
protein at 30uC for 15 min. The RNA was then digested with 0.05 unit of RNase T1
(Sigma) for 10min at 37uC. After incubation the reaction mixture was treated with
proteinase K followed by phenol: chloroform extraction and alcohol precipitation.
The T1 digestions were carried out using nuclease buffer containing 10mM Tris–Cl
(pH 7.5),10mMMgCl2,and100mMKCl.ThedigestedRNAswereprecipitatedwith
0.3Msodiumacetateand2.5volumesofabsoluteethanol.TheprecipitatedRNAwas
reverse-transcribed with an end labeled primer annealing at 39 end of the RNA. The
cDNAs were precipitated with 0.3M sodium acetate and absolute ethanol and then
resolved in 8M urea–8% acrylamide gel along with a reference sequencing reaction
carried out using the same end labeled primer.
NS3protease cleavage assay. Toinvestigate the effectofHCV IRES RNAbinding on
the NS3 protease cleavage activity, the recombinant NS3 protease was allowed to
form complex with increasing amount of cold HCV IRES RNA in binding buffer
(5mM HEPES [pH 7.6], 25mM KCl, 2mM MgCl2, 3.8% glycerol, 2mM
dithiothreitol, 0.1mM EDTA) at 30uC for 30 min. One of the reaction tubes had no
HCV IRES RNA. After incubation at 30uC, NS5A/5B substrate (containing NS3
protease cleavage site) was added to each of the tubes and incubated at 37uCf o r
45 minutes. The reactions were then loaded on a 15% SDS-PAGE, resolved and
subjected for silver-staining.
Transient transfection. pSGR JFH1 luc RNA (5mg) was transiently co-transfected
into monolayer (80% confluent) of Huh7 cells in 35mm dishes with either NS3
pro,
mNS3
pro, core, or La encoding plasmid construct using Lipofectamine 2000 reagent
(Invitrogen) in antibiotic free medium. Cells were harvested at different time points
using Tri reagent (Sigma) for RNA preparation and RT-PCR. To investigate
translation levels, cell lysates were prepared using passive lysis buffer (Promega).
Luciferase activities were measured using Luciferase assay reagent (Promega).
Semi quantitative RT-PCR. RNA was isolated from Huh 7 cells co-transfected with
either HCV dicistronic replicon
15 or H77S RNA
19 (along with either NS3
pro over
expressingplasmidorthevectorcontrol.RNAswerereversetranscribedwithHCV59
primer and GAPDH 39 primer using MMLV RT (Promega) for amplification of
negative strand of HCV RNA. Resulting cDNA was used for PCR amplification
corresponding to HCV IRES. The PCR products were run on 1% agarose gel and
quantitated by densitometry. GAPDH was used as an internal control.
Immunoprecipitation. pSGR JFH1 luc RNA (5mg) was transiently co-transfected
into monolayer (80% confluent) of Huh7 cells in 35mm dishes with either NS3
pro,
mNS3
pro, core, or La expressing plasmid construct using Lipofectamine 2000 reagent
(Invitrogen) in antibiotic free medium. After 18hrs, the cells were lysed with buffer
containing 100 mM KCl, 5 mM MgCl2, 10 mM HEPES (pH 7.0), 0.05% NP-40,
1 mMDTT,100U/mlRNasin,25ml/ml.SupernatantswereincubatedwithantiNS5B
antibody overnight. RNP complexes were precipitated by protein-G sepharose beads
followed by proteinase-K and DNase treatments. Finally phenol-chloroform
extracted and alcohol precipitated RNA was used for RT-PCR for detecting the HCV
IRES. Same protocol was followed for pulling down NS3 - RNA complex from HCV
monocistronic replicon pFKi383hygubiNS3-3_5.1 cell line
21 using anti NS3
antibody. Anti actin antibody was used as negative control.
Two-cycleRNaseprotectionassay.TotalRNAwasselfhybridizedovernightat60uC
in the absence of radiolabelled probe. This was followed by RNase treatment at 7uC
for 1hour in a digestion mix containing 500mM NaCl, 10mM Tris HCl (pH 7.5),
5mM EDTA, 4.5mg RNaseA per ml and 350U RNase T1 per ml. Reaction mix was
subjected to proteinase K treatment followed by phenol chloroform extraction and
ethanol precipitation with 5 mg tRNA. RNA pellet was then suspended in
hybridization buffer containing 75fmol of radiolabelled probe and the samples were
put through the standard RNase protection assay procedure
16.
Strand specific RT-PCR using tagged HCV primer. Total RNAs were reverse
transcribed with tagged HCV 59primer using AMV-RT (Promega). Resulting cDNA
was amplified by nested PCR. Both rounds were performed in a reaction mix
containing0.2mMofeachprimer, 13PCR reaction buffer,0.1mMdNTPmixand 1U
of hot start Taq DNA polymerase (Genei). First round of PCR was performed using
tag only primer and HCV IRES reverse primer. The resulting PCR product was
diluted 50 times and was used for the second round of PCR using a set of internal
primers. GAPDH was amplified as an internal control. Resulting PCR products were
analyzed by 2% agarose gel electrophoresis.
rTthreversetranscriptasePCR.Inthismethodreversetranscriptionwascarriedout
at 60uC for 30 minutes. Reverse transcription activity of the polymerase was
inactivated by chelating Mn
21 by addition of chelating buffer containing 1.5mM
EGTA and heating the reaction mix at 98 uC for 30 minutes. This was followed by
PCR amplification as described earlier
17.
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